CoChat

Adipose lipolysis is important for ethanol to induce fatty liver in the National Institute on Alcohol Abuse and Alcoholism murine model of chronic and binge ethanol feeding

Open access
Mathur, Mallika, Yeh, Yu‐Te, Arya, Rakesh K., Jiang, Long, Pornour, Majid, Chen, Weiping, Ma, Yinyan, Gao, Bin, He, Ling, Ying, Zhekang, Xue, Bingzhong, Shi, Hang, Choi, Youngshim, Yu, Liqing · 2023 · Hepatology
Cited by 45

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Background and Aims: Alcohol‐associated liver disease (ALD) pathologies include steatosis, inflammation, and injury, which may progress to fibrosis, cirrhosis, and cancer. The liver receives ~60% of fatty acids from adipose tissue triglyceride hydrolysis, but the role of this lipolytic pathway in ALD development has not been directly examined in any genetic animal models with selective inactivation of adipose lipolysis. Approach and Results: Using adipose‐specific comparative gene identification‐58 (CGI‐58) knockout (FAT‐KO) mice, a model of impaired adipose lipolysis, we show that mice deficient in adipose lipolysis are almost completely protected against ethanol‐induced hepatic steatosis and lipid peroxidation when subjected to the National Institute on Alcohol Abuse and Alcoholism chronic and binge ethanol feeding model. This is unlikely due to reduced lipid synthesis because this regimen of ethanol feeding down‐regulated hepatic expression of lipogenic genes similarly in both genotypes. In the pair‐fed group, FAT‐KO relative to control mice displayed increased hepatocyte injury, neutrophil infiltration, and activation of the transcription factor signal transducer and activator of transcription 3 (STAT3) in the liver; and none of these were exacerbated by ethanol feeding. Activation of STAT3 is associated with a marked increase in hepatic leptin receptor mRNA expression and adipose inflammatory cell infiltration. Conclusions: Our findings establish a critical role of adipose lipolysis in driving hepatic steatosis and oxidative stress during ALD development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.32675

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy

    Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S., & Goldstein, J. L. (1999) · Nature · doi:10.1038/43448 · Cited by 1,038 · cited 1×

    “As a major adipokine, leptin has been shown to prevent fatty liver in a genetic model of lipodystrophy in mice.[37] Liver‐specific Lepr knockout mice display fatty liver,[38] suggesting a direct role of leptin signaling in suppressing fat deposition in the liver.”
    Background
  • Alcohol effects on hepatic lipid metabolism

    Jeon, S., & Carr, R. (2020) · Journal of Lipid Research · doi:10.1194/jlr.r119000547 · Cited by 326 · cited 1×

    “Multiple mechanisms have been implicated in the pathogenesis of alcohol‐induced hepatic steatosis, including decreases in FA oxidation and VLDL secretion as well as increases in adipose lipolysis, hepatic lipogenesis, and hepatic FA uptake.[30] Surprisingly, we found that hepatic expression levels of mRNAs for F IGURE…”
    Background

Cited by

See all 45

Metadata

Authors
Mathur, M., Yeh, Y., Arya, R. K., Jiang, L., Pornour, M., Chen, W., Ma, Y., Gao, B., He, L., Ying, Z., Xue, B., Shi, H., Choi, Y., & Yu, L.
Venue
Hepatology
Published
2023-04-17
Volume
77
Issue
5
Pages
1688-1701
ISSN
0270-9139 (ISSN-L)
OpenAlex
W4285730633
Cited by
45
References
2
FWCI
5.78
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.